| Preface |
|
v | |
| Acknowledgments |
|
vii | |
| Section I. PRINCIPLES OF DOSAGE FORM DESIGN AND DEVELOPMENT |
|
|
Introduction to Drugs and Pharmacy |
|
|
1 | (22) |
|
New Drug Development and Approval Process |
|
|
23 | (37) |
|
Dosage Form Design: Pharmaceutic and Formulation Considerations |
|
|
60 | (41) |
|
Dosage Form Design: Biopharmaceutic and Pharmacokinetic Considerations |
|
|
101 | (41) |
|
Current Good Manufacturing Practices and Good Compounding Practices |
|
|
142 | (22) |
| Section II. SOLID DOSAGE FORMS AND MODIFIED-RELEASE DRUG DELIVERY SYSTEMS |
|
|
|
|
164 | (15) |
|
|
|
179 | (50) |
|
Modified-Release Dosage Forms and Drug Delivery Systems |
|
|
229 | (15) |
| Section III. SEMI-SOLID AND TRANSDERMAL SYSTEMS |
|
|
Ointments, Creams, and Gels |
|
|
244 | (19) |
|
Transdermal Drug Delivery Systems |
|
|
263 | (16) |
| Section IV. PHARMACEUTICAL INSERTS |
|
|
Suppositories and Inserts |
|
|
279 | (17) |
| Section V. LIQUID DOSAGE FORMS |
|
|
|
|
296 | (50) |
|
|
|
346 | (51) |
| Section VI. STERILE DOSAGE FORMS AND DELIVERY SYSTEMS |
|
|
|
|
397 | (53) |
|
|
|
450 | (19) |
|
Ophthalmic Solutions and Suspensions |
|
|
469 | (18) |
| Section VII. NOVEL AND ADVANCED DOSAGE FORMS, DELIVERY SYSTEMS, AND DEVICES |
|
|
|
|
487 | (16) |
|
Products of Biotechnology |
|
|
503 | (32) |
|
Novel Dosage Forms and Drug Delivery Technologies |
|
|
535 | (17) |
| Appendix Systems and Techniques of Pharmaceutical Measurement |
|
552 | (11) |
| Index |
|
563 | |
Shopping Cart
